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Abstract Our results demonstrate that the novel vasoactive reg- 
ulatory peptide adrenomedullin is a potent mitogen for Swiss 3T3 
cells. Acting via a specific adrenomedullin receptor, it stimulates 
a dose-dependent increase in DNA synthesis in synergy with 
insulin. Additionally, adrenomedullin stimulates further progres- 
sion through the cell cycle resulting in cell proliferation, an effect 
that was further enhanced by the presence of insulin. Adrenome- 
dullin rapidly induces accumulation of intracellular CAMP but 
does not stimulate an increase in intracellular Ca*+, activation of 
protein kinase C, or tyrosine phosphorylation of intracellular 
substrates. Adrenomedullin-stimulated mitogenesis is markedly 
enhanced in Swiss 3T3 cells stably transfected with a constitu- 
tively activated Gsq which are highly sensitive to agents that 
elevate CAMP, and is inhibited by the PKA inhibitor H-89. Adre- 
nomedullin is, thus, identified as a novel mitogenic regulatory 
peptide acting via CAMP. 
Key words: Neuropeptide; Signal transduction; 
Growth control 
1. Introduction 
Adrenomedullin is a novel 50 amino acid peptide which has 
a six-residue intramolecular disulfide-link ring structure and is 
a member of the calcitonin peptide family [1,2]. Adrenome- 
dullin immunoreactivity and mRNA are widely distributed in 
rat and human tissues, including heart, aorta and lung, and the 
peptide is present in plasma [3]. Specific adrenomedullin-bind- 
ing sites have been identified in a range of rat tissues, including 
lung and vascular tissue [4], and in cultured rat vascular smooth 
muscle (VSM) and bovine aortic endothelial (BAE) cells [S]. 
Although these findings suggest that adrenomedullin is a novel 
element in the homeostatic regulatory peptide network, the 
cellular responses and signal transduction pathways stimulated 
by this peptide through specific adrenomedullin receptors have 
not, as yet, been elucidated. 
Previous studies have shown that adrenomedullin stimulates 
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the accumulation of intracellular CAMP in VSM and BAE cells 
and induces a rise in intracellular Ca” via a cholera toxin- 
sensitive G-protein-dependent mechanism in BAE cells [5]. 
However, adrenomedullin mediated increases in intracellular 
CAMP can be blocked by the calcitonin-gene related peptide 
(CGRP) receptor antagonist CGRP Q-37) in some cell types 
[6]. Since adrenomedullin has been shown to interact with 
CGRP receptors and CGRP (8-37) binds very weakly to spe- 
cific adrenomedullin receptors [7], the effects of adrenome- 
dullin observed in some cell lines and tissues may be mediated 
via CGRP receptors. Indeed, the best characterized pharmacol- 
ogical action of adrenomedullin, namely the induction of a 
potent hypotensive response in rats, might be mediated by 
CGRP receptors [8]. However, the rat adrenomedullin recep- 
tor, which belongs to the G-protein-coupled receptor superfa- 
mily characterized by seven transmembrane domains [9], binds 
adrenomedullin but not CGRP [7]. Clearly, the examination of 
the signal transduction pathways activated by specific adre- 
nomedullin receptors and the elucidation of the biological re- 
sponses induced by this novel peptide at the cellular level re- 
quires a cell line which expresses adrenomedullin but not 
CGRP receptors. 
Here, we report that Swiss 3T3 cells, a useful model to iden- 
tify the extracellular and intracellular signals that elicit mito- 
genesis [lo], display specific high-affinity adrenomedullin re- 
ceptors but not CGRP receptors. We show, for the first time, 
that adrenomedullin acts as a potent synergistic mitogen for 
these cells. Adrenomedullin elicits accumulation of intracellular 
CAMP but does not induce Ca2’ mobilization, protein kinase 
C (PKC) activation, or tyrosine phosphorylation of intracellu- 
lar substrates. Thus, our results identify adrenomedullin as a 
novel neuropeptide growth factor acting through specific adre- 
nomedullin receptors to elevate intracellular CAMP. 
2. Materials and methods 
2. I. Materials 
Rat adrenomedullin was obtained from Peptide Institute (Osaka, 
Japan). Iodogen reagent was obtained from Pierce (Rockford, IL). 
Bombesin, insulin, bacitracin, antimouse IgG and phosphoramidon 
were obtained from Sigma. The bromodeoxyuridine (BrDu) labelling 
and detection kit was obtained from Boehringer Mannheim Biochem- 
ica. The Biotrak CAMP RIA kit, [‘ZSI]protein A, ‘*51-labelled sheep 
antimouse IgG and Na12’I were obtained from Amersham (UK). PY20 
and 4GlO anti-Tyr (P) mAbs were obtained from TCS Biologicals 
(UK). Tyr’clCGRP and CGRP (S-37) were obtained from Peninsula 
Laboratory (Belmont, CA) and aCGRP from ASG University 
(Szedegl, Hungary). The Gsa (Q227Las) 3T3 cell line was a kind gift 
from I. Zachary (Department of Medicine, King’s College School of 
Medicine and Dentistry, London, UK). All other reagents were of the 
purest grade available. 
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2.2. Cell culture, DNA synthesis, cellprol@rution and meu~~r~m~t~t of 
bromodeoxyuridine labelling of cell nuclei 
Stock cultures of Swiss 3T3 fibroblasts were maintained as previously 
described in DMEM supplemented with 10% fetal bovine serum (FBS) 
in a humidified atmosphere containing 10% CO, and 90% air at 37°C 
[I I]. Thymidine incorporation assays and the measurement of cell pro- 
liferation were performed as previously described [I I]. The im- 
munofluorescence assay for the detection of BrDu incorporated into 
cellular DNA was performed using the BrDu labelling and detection 
kit from Boehringer Mannheim Biochemica. 
2.3. Peptide iodination 
Rat adrenomedullin was iodinated by the Iodogen (1,3,4.6-tctra- 
chloro-3a,6a-diphenylglycoluril) method [12]. Briefly, 12.5 pg (2 nmol) 
of adrenomedullin in 10 ~1 of 0.2 M phosphate buffer (pH 7.2) were 
reacted with 37 MBq of Na? and 10 pug of Iodogen reagent for 4 min 
at 22°C. The [‘*‘I]peptide was purified by reversed-phase HPLC (Wa- 
ters C,, Novapak, Millipore) using a 1540% acetonitrile/water/0.05% 
trifluoroacetic acid gradient. Fractions showing binding were ali- 
quoted, freeze-dried and stored at -80°C. The specific activity of the 
adrenomedullin label was 10.4 Bq/fmol. Tyr’aCGRP was iodinated by 
the Iodogen method [13]. The specific activity of the CGRP label was 
35.9 Bq/fmol. 
2.4. Receptor-binding assays 
Confluent Swiss 3T3 cells were incubated for 120 min at room tem- 
perature in 1 ml of binding buffer (20 mM HEPES pH 7.4, 5 mM 
MgCl,, 100 mM NaCI, 5 mM KCl, 1 mM EDTA, 1 PM phosphoram- 
don, 0.25 mg/ml bacitracin and 0.1% BSA) containing 1000 Bq ( 100 
PM) [“51]adrenomedu11in. Bound and free label were separated by aspi- 
ration of binding buffer and washing 3 x with binding buffer without 
label at 4°C. Cells were solubilized in 0.1 M NaOH and bound label 
counted. Non-specific binding was determined in the presence of 500 
nM unlabelled rat adrenomedullin. Specific binding was defined as total 
binding minus non-specific binding. CGRP-binding assays were pcr- 
formedusing a similar protocol with the same assaybuffer-and incuba- 
tion conditions except with 1000 Bq (27.8 PM) of Tyr”aCGRP. Non- 
specific binding was determined in the presence of 200 nM rat aCGRP. 
2.5. Measurement of cAMP accumulation 
Quiescent cultures of cells were washed 3 x with DMEM and incu- 
bated with DMEM/Waymouth’s medium (1 : 1 v/v) with factors as 
indicated for the times shown. Medium was then removed and CAMP 
extracted by incubating with 0.1 M HCl for 20 min at 4°C. The HCI 
extract was then neutralized and the CAMP concentration determined 
using the acetylation protocol of the Biotrak CAMP RIA system (Amer- 
sham). Protein determinations were performed by solubilizing the cell 
layer in 1 ml of 2% Na,CO,, 0.1 M NaOH, 1% SDS and using the BCA 
protein assay (Pierce). 
2.6. Measurement of intracellular calcium. antiphosphotyrosine 
immunoprecipitations and HOKIMARCKS phosphorylation 
These procedures were performed as previously described [ 14,151. 
3. Results and discussion 
3.1. [“51]adrenomedullin hinds to intact Swiss 3T3 cells 
To examine whether Swiss 3T3 cells express specific adre- 
nomedullin receptors, quiescent cultures of these cells were 
incubated with ‘251-labelled peptide in the presence of increas- 
ing concentrations of unlabelled adrenomedullin. As shown in 
Fig. 1, upper panel, unlabelled peptide competed with 
[‘251]adrenomedullin for binding to Swiss 3T3 cells in a concen- 
tration dependent manner, with an ZC,, of 3.5 f 0.6 nM and a 
B max of 26.3 f 3.9 fmol/105 cells. In contrast, no binding of 
labelled CGRP could be demonstrated in parallel cultures of 
Swiss 3T3 cells using the same assay conditions (Fig. 1, upper 
panel, inset). As a control we verified that the [“‘IICGRP used 
in these experiments bound specifically to SK-N-MC neuro- 
blastoma cells, a cell line known to express specific CGRP recep- 
tors [4] (Fig. 1, upper panel, inset). Furthermore, neither CGRP 
nor CGRP (8-37) inhibited [‘251]adrenomedu11in-binding to 
Swiss 3T3 cells at concentrations up to 1 PM (results not 
shown). These experiments demonstrate the expression of spe- 
cific adrenomedullin but not CGRP receptors in quiescent 
Swiss 3T3 cells. 
3.2. Adrenomedullin stimulates DNA synthesis and cell 
proliferation 
Regulatory peptides are increasingly implicated in the con- 
trol of cell proliferation [ 161 and, therefore, we next determined 
whether adrenomedullin can act as a growth factor for Swiss 
3T3 cells. Treatment of confluent, quiescent cultures of these 
cells with adrenomedullin, in combination with insulin, stimu- 
lated a dose-dependent increase in [3H]thymidine incorporation 
as shown in Fig. 1, lower panel. The maximum effect was seen 
at 100 nM adrenomedullin and was similar to that achieved 
with the potent neuropeptide mitogen bombesin at fully mito- 
genie concentrations [17]. These results were substantiated by 
the finding that treatment of cells with adrenomedullin stimu- 
lated the incorporation of BrDu into cell nuclei. The maximum 
effect was again seen at 100 nM adrenomedullin, in synergy 
with insulin, with 55 f 0.5% of nuclei being labelled (Fig. 1, 
lower panel, inset). In agreement with the binding data pre- 
sented above, the stimulation of DNA synthesis induced by 
adrenomedullin was not attenuated by the CGRP-antagonist 
CGRP (S-37) at 1 PM (results not shown). Adrenomedullin 
stimulated further progression through the cell cycle resulting 
in cell proliferation. As shown in Table 1, adrenomedullin 
added to cells maintained in conditioned medium elicited a 
statistically significant increase in cell number an effect that was 
further enhanced by the presence of insulin. The results pre- 
sented in Fig. 1 and Table 1 demonstrate for the first time that 
adrenomedullin can synergistically induce long-term stimula- 
tion of DNA synthesis and cell division in cultured cells 
through specific adrenomedullin receptors. 
3.3. Adrenomedullin stimulation qf DNA synthesis is mediated 
via cAMP 
The potent mitogenic activity of adrenomedullin in Swiss 
3T3 cells led us to characterize the signal transduction path- 
ways activated by this neuropeptide in these cells. Adrenome- 
dullin has recently been reported to stimulate an increase in 
intracellular [Ca”] [5] and many other mitogenic neuropep- 
Table I 
Effect of adrenomedullin or bombesin on the proliferation of Swiss 3T3 
cells 
Addition 
Adrenomedullin 
Bombesin 
Cell number (x 10-j) 
_ +Ins 
3.39 2 0.14 4.07 ? 0.08 
4.52 f 0.06* 7.14 + 0.13* 
4.45 f 0.14* 9.15 * 0.08* 
6-day-old cultures of Swiss 3T3 cells in conditioned medium were 
treated with various factors: 100 nM adrenomedullin with 50 PM 
IBMX, or 10 nM bombesin (Born) or control (-) in the absence or 
presence of 1 &ml of insulin ( ? Ins). Cell number was then deter- 
mined after 72 h as described in section 2. Results shown are the 
mean & S.E. values of two experiments performed in qudruplicate. 
*P < 0.001 in Student’s t test compared with control without insulin for 
factors in the absence of insulin and with control with insulin for factors 
in the presence of insulin. 
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tides, including bombesin, stimulate calcium mobilization from 
intracellular stores in Swiss 3T3 cells [18]. Therefore, we as- 
sessed the ability of adrenomedullin to mobilize calcium in 
these cells. As shown in Fig. 2, panel A, adrenomedullin did not 
increase the intracellular [Ca”] over a concentration range 
from 10 to 100 nM (at which levels it has been demonstrated 
to elevate intracellular [Ca”] in BAE cells) whereas subsequent 
addition of bombesin caused a rapid increase in intracellular 
[Ca”]. No mobilization of Ca*’ was seen with adrenomedullin 
in combination with insulin (data not shown). 
In intact cells, the activation of phorbol ester-sensitive 
isoforms of PKC results in the phosphorylation of an acidic 80 
kDa protein 8OK/MARCKS [13]. Fig. 2, panel B, shows that 
phorbol 12,13-dibutyrate (PDB) caused a marked increase in 
the phosphorylation of 8OK/MARCKS whereas adrenome- 
dullin alone or in combination with insulin had no effect. These 
results strongly suggest that adrenomedullin does not activate 
PKC. Additionally, we did not detect any increase in the pro- 
duction of inositol phosphates when [3H]inositol-labelled Swiss 
3T3 cells were treated with adrenomedullin suggesting that this 
peptide does not activate phospholipase C (data not shown). 
Bombesin and other neuropeptides have been shown to stim- 
ulate tyrosine phosphorylation of multiple substrates in Swiss 
3T3 cells, including major bands migrating with apparent mo- 
lecular masses of 60-70 kDa and 110-l 30 kDa [19]. The focal 
adhesion proteins paxillin, ~125~~~ and ~130 are prominent 
tyrosine phosphorylated substrates in neuropeptide-treated 
Swiss 3T3 cells [19]. As shown in Fig. 2, panel C, adrenome- 
dullin did not stimulate tyrosine phosphorylation of any pro- 
teins at concentrations that promote DNA synthesis. 
An increase in the intracellular concentration of CAMP has 
Fig. I. Binding of [1Z51]adrenomedullin to intact Swiss 3T3 cells and 
adrenomedulhn stimulation of DNA synthesis. (Upper) Confluent, qui- 
escent Swiss 3T3 cells were incubated for 2 h at room temperature with 
[‘251]adrenomedulhn in the presence of increasing concentrations of 
cold adrenomedulhn. Bound and free label were separated by washing, 
the cells solubihzed and bound label counted. Specific binding was 
calculated as total binding minus non-specific binding as determined in 
the presence of 500 nM unlabelled adrenomedullin. Results presented 
are the mean f SE. values of three separate experiments each per- 
formed in sextuplet. (Upper, inset) Confluent, quiescent Swiss 3T3 and 
SK-N-MC cells were incubated for 2 h with [‘*‘I]CGRP. Bound and free 
label were separated by washing, the cells solubihzed and bound label 
counted. Specific binding was calculated as total binding minus non- 
specific binding as determined in the presence of 500 nM CGRP and 
is presented as cpm/106 cells. The results shown are the mean + SE. 
values of three separate experiments each performed in sextuplet. 
(Lower) Confluent, quiescent cultures of Swiss 3T3 cells were incubated 
in DMEM/Waymouth medium containing [‘Hlthymidine and increas- 
ing concentrations of adrenomedullin in the presence of 50pM IBMX 
and 0.5 ,ug/ml insulin. After 40 h, DNA synthesis was assessed by 
measuring the [iH]thymidine incorporated into acid-precipitable mate- 
rial. Results are expressed as a percentage of the incorporation induced 
by 10% FBS, and data are shown as mean k S.E. (n = 12). (Lower, 
inset) Confluent, quiescent cultures of Swiss 3T3 cells were incubated 
in DMEMiWaymouth medium containing bromodeoxyuridine (BrDu) 
labelling reagent and vehicle (-). 0.5 pg/ml insulin (Ins) and 100 nM 
adrenomedullin with 50 PM IBMX in the absence (AM) or presence 
(AM+Ins) 0.5 &ml insulin. After 40 h, BrDu incorporation into cell 
nuclei was determined by using a specific antibromodeoxyuridine mon- 
oclonal antibody detected by a fluoroscein-conjugated secondary anti- 
body. Labelled nuclei were visualized by fluorescence microscopy. Re- 
sults are presented as the% labelled nuclei k S.E. in five distinct fields 
from two separate experiments. 
85 
been identified as one of the mitogenic signals for Swiss 3T3 
cells [lO,l l] and adrenomedullin has been shown to elevate 
CAMP in several cell types [1,5]. Consequently, we examined 
whether adrenomedullin also increases CAMP in Swiss 3T3 
cells. As shown in Fig. 3, adrenomedulhn stimulated a rapid rise 
in intracellular CAMP levels (to 6-fold above basal levels) which 
peaked within 5 min of addition and persisted for at least 3 h. 
Adrenomedullin increased intracellular CAMP in a dose-de- 
pendent manner with a maximal response seen at 10 nM (Fig. 
3, inset). The results presented in Figs. 2 and 3 indicate that 
adrenomedullin acts via CAMP rather than through phospho- 
lipase C-dependent signalling pathways utilized by many other 
mitogenic regulatory peptides. 
We utilized two additional experimental approaches to pro- 
vide further evidence that the mitogenic effects of adrenome- 
dullin are mediated via elevation of intracellular CAMP. Swiss 
3T3 cells stably transfected with a constitutively activated Gsa 
subunit are highly sensitive to agents that elevate CAMP [20]. 
In these cells, adrenomedullin-stimulated mitogenesis was 
markedly enhanced with a shift in the dose response such that 
maximal DNA synthesis was seen at a concentration as low as 
0.1 nM (Fig. 4). To further investigate the role of CAMP in 
adrenomedullin-stimulated DNA synthesis, we utilized the 
PKA inhibitor H-89 [21]. As shown in Fig. 5, inset, addition of 
5 PM H-89 resulted in a 50% inhibition of adrenomedullin- 
o-11 ’ I I 
0.01 0.1 1.0 10 100 
Adrenomedullin (nM) 
ob ’ I 
0.01 0.1 1.0 10 100 
Adrenomedullin (nM) 
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stimulated DNA synthesis while no effect was seen on EGF- 
stimulated mitogenesis, which is not mediated via CAMP [IO]. 
3.4. Conclusions 
An increasing number of neuropeptides and vasoactive pep- 
tides have been shown to act as local hormones or transmitters 
exerting their actions in a paracrine or autocrine manner [22]. 
These regulatory peptides elicit a wide range of short-term 
A 1189 ) 1198 ) 
A [ caM2+]i 
c I 246 + 241 +- 
4 1 
AM Born 
10 
4 4 
AM Born 
100 
B 
aoK/ * 
MARCKS -AM AM PDB 
10 100 
Anti-Tyr(P) 
- AM Born -AM Born 
10 100 
Fig. 2. Adrenomedullin does not induce Ca” mobilization, PKC activa- 
tion, or tyrosine phosphorylation of intracellular substrates. (A) Con- 
fluent, quiescent cultures of Swiss 3T3 cells were washed and loaded for 
15 min with Fura- and then scraped and transferred to a cuvette. The 
cells were stirred at 37°C in a Perkin-Elmer LS5 luminescence spectro- 
photometer and fluorescence was measured and recorded continuously. 
Adrenomedullin at doses of 10 nM (AM 10) and 100 nM (AM 100) were 
used in separate experiments. Bombesin at 10 nM (Born) was added 
after the adrenomedullin as a positive control. Results are expressed as 
calculated increase in intracellular Ca” in nM ([Ca”],) and are repre- 
sentative of three independent experiments. (B) Confluent dishes of 
Swiss 3T3 cells were incubated overnight in phosphate-free DMEM 
with 50 ,UZi/ml “P,, Cells were treated for 10 min with vehicle (-), 
adrenomedullin (with 50 ,uM IBMX) at doses of IO nM (AM 10) and 
100 nM (AM 100) or 200 nM phorbol 12,13-dibutyrate (PDB). The cells 
were lysed, 80K/MARCKS immunoprecipitated with a specific anti- 
body and the immunoprecipitates analysed by SDS-PAGE and subse- 
quent autoradiography. (C) Quiescent cultures of Swiss 3T3 cells were 
treated for 5 min with vehicle (-), adrenomedullin (with 50,~M IBMX) 
at doses of 10 nM (AM 10) and 100 nM (AM 100) or bombesin at 10 
nM (Born), lysed and proteins were immunoprecipitated at 4°C over- 
night with a monoclonal antibody directed against phosphotyrosine. 
After separation by SDS-PAGE, proteins were transferred to Immo- 
bilon membranes which were incubated in 5% non-fat dried milk in 
phosphate-buffered saline with a mixture of PY20 and 4GlO an- 
tiphosphotyrosine monoclonal antibodies. Immunoreactive bands were 
visualized using ‘251-labelled sheep antimouse IgG followed by autora- 
diogrdphy. 
5C 
40 
0 
Aarenomeauliin (nM) 
10 20 30” 60 180 
Time (min) 
Fig. 3. Time- and dose-dependent stimulation of the intracellular accu- 
mulation of CAMP by adrenomedullin. Confluent, quiescent cultures 
of Swiss 3T3 cells were incubated for various times in the presence of 
100 nM adrenomedullin with 50,~M IBMX. The medium was removed 
and CAMP was extracted by incubating with 0.1 M HCl and CAMP 
concentration determined using a specific RIA. Results are expressed 
as pmol/mg of cellular protein and are the mean f S.E. values of three 
separate experiments each performed in duplicate. Where error bars are 
not visible, they lie within the borders of the symbol. (Inset) Confluent, 
quiescent cultures of Swiss 3T3 cells were incubated for 15 min in the 
presence of increasing concentrations of adrenomedullin with 50 ,uM 
IBMX. The medium was removed and CAMP was extracted by incubat- 
ing with 0.1 M HCI and CAMP concentration determined using a 
specific RIA. Results are expressed as pmol/mg of cellular protein and 
are the mean f SE. values of three separate experiments each per- 
formed in duplicate. Where error bars are not visible, they lie within 
the borders of the symbol. 
physiological events such as neuronal excitation and are in- 
creasingly implicated in the long-term modulation of cell 
growth and differentiation. The results presented here demon- 
strate, for the first time, that the vasoactive regulatory peptide 
adrenomedullin is a potent growth factor for quiescent cultures 
of Swiss 3T3 cells incubated in the presence of insulin. 
Many mitogenic neuropeptides, such as bombesin, vaso- 
pressin, bradykinin and endothelin, elicit their effects via poly- 
phosphoinositide hydrolysis leading to elevation of intracellu- 
lar Ca7+ and activation of PKC [22]. These peptides also pro- 
mote cytoskeletal reorganization and tyrosine phosphorylation 
of focal adhesion proteins [19]. In contrast, our results indicate 
that the mitogenic effects of adrenomedullin are elicited via the 
elevation intracellular CAMP which is one of the mitogenic 
signals for Swiss 3T3 cells [ 10,l 11. Acting via specific adrenome- 
dullin, but not CGRP receptors, adrenomedullin stimulates a 
persistent elevation in intracellular CAMP but does not pro- 
mote an increase in intracellular [Ca’+], activation of PKC or 
the tyrosine phosphorylation of distinct intracellular sub- 
strates. Further evidence that the mitogenic effects of adre- 
nomedullin are mediated via its ability to elevate intracellular 
CAMP comes from the use of Swiss 3T3 cells stably transfected 
with a constitutively activated Gsa subunit. Thus, the findings 
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Fig. 4. Adrenomedullin stimulates mitogenesis via elevation of CAMP 
in Swiss 3T3 cells Confluent, quiescent cultures of either wild type Swiss 
3T3 cells (B) or Swiss 3T3 cells stably transfected with an activated Gsa 
subunit [Gsa(Q227Las)3T3] (0) were incubated in DMEM/Waymouth 
medium containing [3H]thymidine and increasing concentrations of 
adrenomedullin in the presence of 50 PM IBMX and 0.5 &ml insulin. 
After 40 h, DNA synthesis was assessed by measuring the [‘Hlthymid- 
ine incorporated into acid-precipitable material. Results are the mean 
values of duplicates, are expressed as a percentage of the incorporation 
induced by 10% FBS, and are representative of three independent 
experiments. (Inset) Confluent, quiescent cultures of Swiss 3T3 cells 
were incubated in DMEM/Waymouth medium containing [‘Hlthymid- 
ine either 100 nM adrenomedullin with 50 PM IBMX and 0.5 &ml 
insulin (AM) or 5 ng/ml EGF with 0.5 &ml insulin (EGF) in the 
presence or absence of 5 PM H-89. After 40 h, DNA synthesis was 
assessed by measuring the [‘Hlthymidine incorporated into acid-precip- 
itable material. Results are expressed as a percentage of the incorpora- 
tion induced by 10% FBS and are the mean f S.E. values of two exper- 
iments performed in duplicate. 
presented here support the existence of multiple signalling path- 
ways in the mitogenic actions of regulatory peptides and imply 
that the role of these peptides in the control of cell proliferation 
is likely to be broader than previously anticipated. 
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